Rhaeos
IL - EvanstonBiotechnology
Focus: Rhaeos is a medical device biotech focused on shunt monitoring for hydrocephalus using thermal anisotropy measurement technology. The company operates as a pre-revenue stage innovator with minimal public disclosure on scale or market position.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Rhaeos
AI assessmentNot HiringNo open roles listed right now. Follow Rhaeos to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
15 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
FlowSense
Stable
Early Development
Lead product candidate using wireless thermal anisotropy measurement for non-invasive shunt flow monitoring.
Rhaeos Shunt Monitoring System
Help build intelligence for Rhaeos
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.